{"title":"Sports betting, alcohol problems follow similar trajectories: Study","authors":"Gary Enos","doi":"10.1002/adaw.34447","DOIUrl":"https://doi.org/10.1002/adaw.34447","url":null,"abstract":"<p>Research evidence continues to suggest that sports bettors carry an elevated risk of alcohol-related problems, with a newly published longitudinal study showing similar trajectories between gambling frequency and alcohol problems. There is even some evidence that problematic drinking levels are more prevalent among sports gamblers than among gamblers who don't wager on sports.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 11","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143632530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Drug and Alcohol Facts Week","authors":"Alison Knopf","doi":"10.1002/adaw.34452","DOIUrl":"https://doi.org/10.1002/adaw.34452","url":null,"abstract":"<p>This week is National Drug and Alcohol Facts Week (NDAFW), an annual event focused on the science of drug use and addiction. The focus is on educating youth and empowering them to make informed decisions, according to the National Institute on Drug Abuse (NIDA), which sponsors the week. Organizations are encouraged to register their events. In exchange, they will receive the following benefits: a listing on NIDA's online events map, the ability to connect with NIDA staff who can offer assistance and answer questions, and increasing visibility of the organzation. The week is March 17-23. To register your event, go to https://nida.nih.gov/research-topics/national-drug-alcohol-facts-week/register-your-event.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 11","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143632710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Industry considers concerns about masking in MDMA trials","authors":"Alison Knopf","doi":"10.1002/adaw.34448","DOIUrl":"https://doi.org/10.1002/adaw.34448","url":null,"abstract":"<p>Not for the first time, experts have expressed concern about whether randomized controlled trials (RCTs) can be conducted with psychedelics. A placebo for a drug with such a powerful effect would be difficult to create. But placebos are needed to prove that a medication works because it works, not because the patient thinks it will (the so-called “placebo effect”). To avoid the placebo effect misguiding results, participants are “blinded” as to whether they are taking the placebo or the study drug. (In “double-blind” studies, the researchers don't know, either.)</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 11","pages":"4-5"},"PeriodicalIF":0.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143632712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Coming Up…","authors":"","doi":"10.1002/adaw.34454","DOIUrl":"https://doi.org/10.1002/adaw.34454","url":null,"abstract":"<p>The <b>Collaborative Perspectives on Addiction Meeting</b> will be held <b>April 3-5, 2025</b> in Providence, Rhode Island. For more information, go to https://addictionpsychology.org/conventions/cpa/2025-collaborative-perspectives-addiction-meeting</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 11","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143632715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical practice guideline on benzodiazepine tapering available from ASAM","authors":"Alison Knopf","doi":"10.1002/adaw.34453","DOIUrl":"https://doi.org/10.1002/adaw.34453","url":null,"abstract":"<p>Last week the American Society of Addiction Medicine released a joint guideline on benzodiazepine tapering. Developed with 10 medical societies, the guideline focuses on strategies to help clinicians determine whether a given patient needs to taper from benzodiazepine medications, and if so, the best way to do so. Benzodiazepines are approved to treat many conditions, including anxiety, mood disorders, insomnia, and seizures. However, benzodiazepine use is also associated with risk of overdose (especially in combination with opioids and alcohol), motor vehicle accidents, falls, and cognitive impairment. When patients take benzodiazepines for more than a month, abrupt discontinuation should not be attempted; rather, the medication must be tapered under clinical supervision. For the guideline, go to Download Guideline.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 11","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143632714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Continuing resolution instead of appropriations: Better than a shutdown","authors":"Alison Knopf","doi":"10.1002/adaw.34446","DOIUrl":"https://doi.org/10.1002/adaw.34446","url":null,"abstract":"<p>Last week, Congress considered the continuing resolution (CR) allowing the government to function through March 14. Then-President Biden himself signed this CR in December 2024. The choice is, as always, between the final appropriations bills or a CR, to avoid a government shutdown. The House of Representatives passed the bill March 11 by a 217-213 vote.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 11","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143632791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"West Virginia considering shutting down OTPs","authors":"Alison Knopf","doi":"10.1002/adaw.34451","DOIUrl":"https://doi.org/10.1002/adaw.34451","url":null,"abstract":"<p>In West Virginia, where pressuring opioid treatment programs (OTPs) has been an ongoing treatment barrier for years, the latest the legislation has offered is a bill that would ban the treatment. Under the bill, sponsored by State Sen. Eric Tarr, West Virginia state code would be changed to outlaw opioid treatment programs that distribute methadone.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 11","pages":"7"},"PeriodicalIF":0.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143632709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pushing the boulder","authors":"Rob Kent","doi":"10.1002/adaw.34450","DOIUrl":"https://doi.org/10.1002/adaw.34450","url":null,"abstract":"<p>People often ask me why our response to the COVID crisis has been different than the response to the overdose epidemic.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 11","pages":"6"},"PeriodicalIF":0.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143632711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"UNODC: Opium prices in Afghanistan, support for disabilities","authors":"Alison Knopf","doi":"10.1002/adaw.34449","DOIUrl":"https://doi.org/10.1002/adaw.34449","url":null,"abstract":"<p>The UN Office on Drugs and Crime (UNODC), meeting last week in Vienna, released new information showing that skyrocketing prices for opium in Afghanistan are benefitting large-scale drug traffickers. In addition, the UNODC announced new partnerships to promote rights and opportunities for people with disabilities.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 11","pages":"5-6"},"PeriodicalIF":0.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143632713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"NIAAA mouse study finds biological underpinnings of AUD","authors":"Alison Knopf","doi":"10.1002/adaw.34439","DOIUrl":"https://doi.org/10.1002/adaw.34439","url":null,"abstract":"<p>Stress and trauma are known to be connected to psychiatric disorders, including alcohol use disorders (AUDs). But until scientists at the federal National Institute on Alcohol Abuse and Alcoholism (NIAAA) identified an area of the brain that may coordinate the response to trauma, much of the biological underpinnings of this connection were not clear.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 10","pages":"4-6"},"PeriodicalIF":0.0,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143571168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
